US biotechnology firm Moderna on Monday said lab studies showed its COVID-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa, AFP reports.
The company added that out of caution, it will test adding a second booster of its vaccine and has begun preclinical studies on a booster specifically for the South African variant.
Read more